written on 16.05.2014

Abbott buys Chile's CFR Pharmaceuticals in $2.9bn deal


Santiago-based CFR is one of the leading branded generics firms in Latin America with a presence in 15 markets. Abbott has additional strength in Brazil and Mexico and sees the opportunity to expand CFR's product portfolio into those markets.